Faeth Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.1% | -25.1% | -24.0% |
| FY2022 | -47.0% | -47.0% | -41.0% |
| FY2023 | -52.5% | -52.5% | -45.9% |
| FY2024 | -78.6% | -78.6% | -66.5% |
| FY2025 | -113.4% | -113.4% | -92.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.1% | -25.1% | -24.0% |
| FY2022 | -47.0% | -47.0% | -41.0% |
| FY2023 | -52.5% | -52.5% | -45.9% |
| FY2024 | -78.6% | -78.6% | -66.5% |
| FY2025 | -113.4% | -113.4% | -92.1% |